Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “PENTOBARBITAL”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 37 records · Page 2Linked to original sources
PubMed1996

Effects of drug discrimination history on the generalization of pentobarbital to other drugs.

In pigeons trained to discriminate between pentobarbital and saline, pentobarbital, amobarbital and diazepam substituted for pentobarbital, whereas phencyclidine (PCP) substituted in part for pentobarbital and d-amphetamine, morphine and drug vehicles did not substitute. After morphine replaced pentobarbital as the training drug (group A), morphine, pentobarbital and diazepam substituted, PCP substituted in part, but not d-amphetamine, haloperidol and vehicles. After d-amphetamine replaced pentobarbital as the training drug (group B), d-amphetamine, pentobarbital and diazepam substituted, PCP substituted in part, but not haloperidol, morphine and vehicles. Next, morphine and d-amphetamine were reversed as training drugs for the two groups. In group A, morphine, d-amphetamine, pentobarbital and diazepam substituted, PCP substituted in part, but not haloperidol and vehicles. Similar effects were observed in group B. Next, birds in group A were reinforced for responses on the drug key (red key) after d-amphetamine and on the previous saline key (green key) after pentobarbital. In group B, morphine continued as the training drug for the red key, whereas responses on the green key were reinforced after pentobarbital. In group A, d-amphetamine, morphine, d-pentazocine and to some extent PCP, produced responding on the red key, whereas pentobarbital, diazepam, haloperidol and the vehicles produced responding on the green key. Similar results were obtained in group B. Finally, responses were reinforced on the green key after pentobarbital and on the red key after saline. Group B did not learn this discrimination. In group A, responding occurred on the red key after d-amphetamine, morphine, haloperidol and vehicles, in part after d-pentazocine, but not after pentobarbital, diazepam and PCP. These experiments show that drug stimuli can continue to exert stimulus control over behavior for long periods, even when training with several other drug stimuli intervenes between tests, and the experiments also show that through sequential training procedures multiple drugs can serve as discriminative stimuli for the same response, even when these drugs are from different phamacological classes.

Animals↗
PubMed1976

Pentobarbital inhibition of progesterone-induced behavioral estrus in ovariectomized guinea pigs.

Administration of pentobarbital inhibits the facilitatory effects of progesterone on the release of gonadotropins. In this experiment facilitatory effects of progesterone on lordosis behavior in guinea pigs were examined with pentobarbital anesthesia. Two major animal groups were subjects: one was short-term ovariectomized (2 weeks) and the other was long-term ovariectomized (several months). All animals received estradiol benzoate (6.6 mug s.c.) followed by progesterone (0.4 mg s.c.) 40 h later. Lordosis behavior was induced by the manual stimulation method of Young et al.29 Sodium pentobarbital (30 mg/kg) was injected 8,4 or 2 h before, simultaneously or 1, 2, 6, or 7 h after progesterone. Animals which received pentobarbital slept for 4.5-5 h with subsequent drowsiness for an additional 0.5-1 h. Pentobarbital injections given 8 h before progesterone had no effect on latency to the first lordosis or on other parameters of estrous behavior. However, pentobarbital delayed the onset of heat in estrogen treated ovariectomized guinea pigs when given 4 h before, 2 h before, or simultaneously with progesterone. The delay was directly related to the length of time the animals remained asleep after the progesterone injection, since estrous behavior was invariably displayed with the latency of controls after the animal awoke. Moreover, in animals which were awake for 1-2 h immediately after the progesterone injection before receiving pentobarbital, the latency of recovery from anesthesia to the first display of lordosis was about 1-1.5 h shorter than in the other pentobarbital groups. In contrast to the latency effects of pentobarbital, the duration of heat was unaffected by the anesthetic for all groups mentioned. In animals which received pentobarbital after they were already in heat, pentobarbital injection terminated heat and abolished it completely, since lordosis behavior was not displayed in the hours after recovery from anesthesia. Gross hypothalamic uptake of progesterone was not influenced by pentobarbital administration. Thus, it is tentatively concluded that an incubation period is necessary for progesterone to mediate the display of estrous behavior in the guinea pig in addition to the time necessary for neural uptake. The way in which pentobarbital interferes with the period of progesterone incubation is not currently known.

Animals↗
PubMed1999

Cerebral hemodynamic effects of pentobarbital coma in head-injured patients.

The purpose of this study was to examine the changes in cerebral hemodynamics of head-injured patients undergoing barbiturate treatment of refractory intracranial hypertension. Cerebral blood flow (CBF) and metabolism variables were measured in 67 severely head-injured patients at the following times: before the loading dose of pentobarbital; after the loading dose of pentobarbital (average pentobarbital level 28.1+/-8.3 microg/mL); and 3 days later, when the peak pentobarbital level averaged 42.5+/-17.2 microg/mL. Intracranial pressure (ICP) and mean arterial blood pressure (MAP) were decreased by the loading dose of pentobarbital by an average of 12 and 9 mm Hg, respectively. Cerebral perfusion pressure (CPP) was unchanged when the entire group was analyzed together. CBF, cerebral oxygen consumption (CMR(O)2), and arteriovenous oxygen difference (AVD(O)2) were significantly decreased after the loading dose of pentobarbital, by 20%, 31%, and 11%, respectively. The average cerebrovascular resistance (CVR) was increased by 20%. The change in CMR(O)2 with the loading dose of pentobarbital was closely related to the pretreatment value (n = 67, r2 = 0.65, p < .001). Thirty (45%) of the patients had a "good ICP response," with a reduction in ICP from 34+/-9 to 15+/-5 mm Hg after the initial loading dose of pentobarbital. Twenty-seven (40%) of the patients had a "partial ICP response," with ICP decreasing but still remaining above 20 mm Hg after the loading dose of pentobarbital. In the remaining 10 patients, ICP did not change or even increased after pentobarbital. In the 30 patients with a good ICP response, pretreatment CMR(O)2 and AVD(O)2 were greater before administration of pentobarbital, and CMR(O)2 and AVD(O)2 decreased more with the loading dose of pentobarbital, than in the patients with partial or no ICP response. The outcome was significantly better in the patients with a good or partial ICP response to pentobarbital, with 21% of these patients having a good recovery or moderate disability at 3 months after injury, compared with 100% persistent vegetative state or death in the nonresponders. In summary, barbiturate coma can be a useful treatment modality for acutely reducing ICP in selected patients. Patients with overwhelmingly severe injuries are not likely to benefit, partly because their CMR(O)2 is already markedly reduced by the injury and partly because their outcome is already predetermined by the injury. Patients with systemic hypotension are not likely to have a good response because hypotension limits the amount of barbiturates that can be given.

Adult↗
PubMed2001

Discrimination of pentobarbital doses and drug mixtures under fixed-ratio and fixed-interval reinforcement schedules.

Pigeons were trained to discriminate among 5 mg/kg pentobarbital, 10mg/kg pentobarbital, and saline, under either fixed-interval (FI) or fixed-ratio (FR) reinforcement schedules. When baseline responding stabilized, a higher percentage of responses occurred on the key that produced the reinforcer under the FR schedule than under the FI schedule. After low doses of pentobarbital, responding shifted from the saline key to the 5 mg/kg pentobarbital key; at higher doses of pentobarbital responding shifted to the 10mg/kg pentobarbital key under both schedules. After low doses of ethanol and chlordiazepoxide, responding shifted from the saline key to the 5 mg/kg pentobarbital key, but after high doses of these drugs, responding continued to occur on the 5 mg/kg pentobarbital key under both reinforcement schedules. A 5 mg/kg dose of pentobarbital increased responding on the 10 mg/kg pentobarbital key when it was combined with pentobarbital, ethanol or chlordiazepoxide. Phencyclidine and D-amphetamine produced responding largely on the saline key under both reinforcement schedules. Under the FR schedule, pentobarbital dose-response curves were usually quantal, whereas under the FI schedule the pentobarbital dose-response curves usually were graded.

Animals↗
PubMed2002

Pentobarbital depressant effects are independent of GABA receptors in auditory thalamic neurons.

Pentobarbital, a general anesthetic, has received extensive study for its ability to potentiate inhibition at GABA(A) subtype of receptors for GABA. Using whole cell current-clamp techniques and bath applications, we determined the effects of pentobarbital and GABA receptor antagonists on the membrane properties and tonic or burst firing of medial geniculate neurons in thalamic slices. Pentobarbital (0.01-200 microM) induced depressant effects in 50 of 66 neurons (76%). Pentobarbital hyperpolarized neurons by a mean of 3 mV and decreased the number of action potentials in tonic firing, evoked by current pulse injection from near the resting potential. Pentobarbital also decreased burst firing or low threshold Ca(2+)-spikes, evoked by current pulse injection into neurons at potentials hyperpolarized from rest. The blockade of tonic and burst firing, as well as low threshold Ca(2+)-spikes, was surmountable by increasing the amplitude of input current. The GABA(A) receptor antagonists, bicuculline (100 microM) and picrotoxinin (50-100 microM), did not block the depressant effects of pentobarbital (10 microM). The GABA(B) receptor antagonist, saclofen (200 microM), and GABA(C) receptor antagonist, (1,2,3,6-tetrahydropyridine-4-yl)methylphosphinate (10-50 microM), did not significantly alter the depressant effects. Pentobarbital produced excitatory effects (0.1-50 microM) on 11 neurons (17%) but had no effects on 5 neurons (7%). The excitation consisted of approximately 3 mV depolarization, increased tonic and burst firing and the rate of rise and amplitude of low threshold Ca(2+) spikes. These effects were associated with a increase in input resistance. In contrast, the depressant effects of pentobarbital correlated to a decreased input resistance measured with hyperpolarizing current pulse injection (IC(50) = 7.8 microM). Pentobarbital reduced Na(+)-dependent rectification on depolarization and lowered the slope resistance over a wide voltage range. Tetrodotoxin eliminated both Na(+)-dependent rectification and the pentobarbital-induced decrease in membrane resistance at depolarized voltages in two-thirds of the neurons. The pentobarbital-induced decrease in membrane resistance at voltages hyperpolarized from rest was not evident during co-application with Cs(+), known to block the hyperpolarization-activated rectifiers. In summary, the pentobarbital acted at low concentrations to depress thalamocortical neurons. The depression resulted from decreased rectification on depolarization, which no longer boosted potentials over threshold, and an increased conductance that shunted spike generation. The depressant effects of pentobarbital did not involve known types of GABA receptor interactions.

Animals↗
PubMed1997

Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.

In the present study, four non-drug-abusing humans were trained to discriminate between a hypnotic dose of pentobarbital, 100 mg, and placebo. After acquiring the pentobarbital-placebo discrimination, a range of doses of zolpidem, triazolam, pentobarbital and caffeine were tested to determine whether they shared discriminative stimulus effects with the training dose of pentobarbital, Zolpidem, a rapid-onset, short-duration, quickly eliminated imidazopyridine hypnotic agent, was tested because its discriminative stimulus effects have been shown to differ from those of classic sedative/hypnotic compounds in rodents, but not in nonhuman primates. Triazolam and caffeine were included as positive and negative controls, respectively. The subject-rated and performance-impairing effects of zolpidem, triazolam, pentobarbital and caffeine were assessed concurrently. These four subjects met the discrimination criterion (> or = 80% correct drug identifications on four consecutive seasions) in 4 to 18 (mean = 8.5) sessions, and the pentobarbital-placebo discrimination was well maintained during a test-of-novel-doses and test-of-novel-drugs phase (i.e., placebo and 100 mg pentobarbital occasioned 0-35% [mean = 17%] and 75-100% [mean = 85%] drug-appropriate responding, respectively). Zolpidem, triazolam and pentobarbital generally produced dose-related increases in pentobarbital-appropriate responding and sedative-like, subject-rated drug effects. Caffeine on average produced low levels of pentobarbital-appropriate responding, although some doses of caffeine produced maximal pentobarbital-appropriate responding in some subjects. Caffeine produced some stimulant-like (e.g., jittery, motivated, nervous and stimulated) subject-rated drug effects. Zolpidem and triazolam, and to a much lesser extent pentobarbital, but not caffeine, impaired performance. These results suggest that humans can acquire and maintain a pentobarbital-placebo discrimination, and this discrimination is pharmacologically specific. These results also suggest that despite the somewhat unique biochemical profile of zolpidem, its discriminative stimulus, subject-rated and performance-pairing effects are similar to those of classic sedative/hypnotic compounds like the barbiturates and benzodiazepines. Finally, the results observed in the present study with zolpidem, triazolam and caffeine demonstrate that the discriminative stimulus effects of drugs observed with nonhuman primates can be systematically replicated in humans.

Adult↗
PubMed1976

Systematic assessment of tolerance to pentobarbital by pellet implantation.

Rapid tolerance development to pentobarbital by pentobarbital pellet implantation was evidenced by a decrease in sleeping time after challenge with different doses of sodium pentobarbital ranging from 37.5 to 100 mg/kg i.p. or a fixed dose of 75 mg/kg i.p. of the drug. The sleeping time produced by sodium pentobarbital decreased by 50% after 1 day. After 2 or 3 days of implantation, the sleeping time was generally further decreased to 15 to 20% of the placebo control group. Tolerance to pentobarbital was still evident 72 hours after pellet removal. The tolerance development to pentobarbital by pentobarbital pellet implantation also was demonstrated by other pentobarbital-induced responses such as hypothermia and lethality. In mice implanted with a 75-mg pentobarbital pellet for 3 days, the degree and duration of pentobarbital-induced hypothermia by intraperitoneal or intracerebral administration of the drug was attenuated. The chronic administration of pentobarbital by three days of pellet implantation reduced the effect of sodium pentobarbital on lethality as evidenced by an increase in the LD50 of sodium pentobarbital after intraperitoneal or intracerebral administration of the drug.

Animals↗
PubMed1982

The effects of food deprivation and satiation on oral pentobarbital self-administration in rhesus monkeys.

The effects of food deprivation and satiation on oral pentobarbital self-administration were studied in four rhesus monkeys. Pentobarbital (1.0 mg/ml) or water was available during alternate daily 3-hr session; between sessions, water was freely available. Lip contacts on a drinking spout activated a solenoid operated liquid delivery system. Liquid deliveries (0.56 ml) occurred after a fixed number of lip contact responses were emitted; that is, liquids were delivered according to fixed-ratio (FR) schedules. Under food deprivation conditions, pentobarbital-maintained behavior exceeded water-maintained behavior. Thus, pentobarbital functioned as a reinforcer. Abrupt unlimited access to food resulted in decreased pentobarbital intake. Pentobarbital-maintained behavior increased to previous levels when food intake was again restricted. In a second experiment, the effects of pentobarbital availability on water-maintained behavior were studied. Access to pentobarbital during alternate sessions produced elevated levels of water drinking during intervening sessions. Water drinking decreased to low levels when pentobarbital access was terminated and water was present for consecutive sessions. When pentobarbital was again available during alternate sessions, high levels of water drinking recurred. In the third experiment, water and pentobarbital (1.0 mg/ml) were concurrently available via separate drinking spouts. All three monkeys drank much more pentobarbital solution than water.

Administration, Oral↗
PubMed1986

Differential modification of pentobarbital stimulus control by d-amphetamine and ethanol.

The ability of d-amphetamine and ethanol to alter discriminative stimulus control by pentobarbital was examined in pigeons. Saline and pentobarbital (5.6 mg/kg) were established as discriminative stimuli for food-maintained responding in six birds. Dose-response functions for stimulus control and response rate were determined for pentobarbital alone and in combination with selected doses of d-amphetamine or ethanol. In tests of stimulus generalization, d-amphetamine alone did not exert pentobarbital-like stimulus control, while ethanol alone evoked variable degrees of pentobarbital-like stimulus control. d-Amphetamine attenuated pentobarbital stimulus control. Doses of 1.0 or 3.2 mg/kg d-amphetamine increased the dose of pentobarbital required for stimulus control in five of six birds. Combinations of high d-amphetamine and pentobarbital doses yielded less than additive rate suppression. Ethanol produced variable effects on pentobarbital stimulus control, with moderate doses generally decreasing, and high doses increasing, the dose of pentobarbital required for stimulus control. A high ethanol dose decreased the pentobarbital dose required for rate suppression. Taken together, these data demonstrate that pentobarbital stimulus control can be altered by drugs within or without the sedative hypnotic class.

Animals↗
PubMed2003

Pentobarbital modulates intrinsic and GABA-receptor conductances in thalamocortical inhibition.

We investigated interactions of an anesthetic barbiturate, pentobarbital, with non-ligand gated channels and identified inhibitory synaptic transmission in thalamic neurons. Using whole cell voltage-clamp, current-clamp and single channel recording techniques in rat ventrobasal neurons of slices and dispersed preparations, we determined the mechanisms of pentobarbital actions on ionic currents and inhibitory postsynaptic currents (IPSCs), mediated by aminobutyric acid (GABA). We investigated pentobarbital effects on intrinsic currents using hyperpolarizing voltage commands from rest and tetrodotoxin blockade of action potentials. At concentrations near 8 microM, pentobarbital increased input conductance and induced net outward current, I(PB), at potentials near action potential threshold. The reversal potential of I(PB) was -75 mV, implicating K+ and other ions. Cs+ (3 mM) which inhibits both K+ currents and inward rectifier (Ih), completely blocked IPB, whereas the selective Ih blocker, ZD-7288 (25 microM), or Ba2+ (2 mM) which suppresses only K+ currents, reduced IPB. Pentobarbital inhibited the Ih, consistent with a ZD-7288-induced shift in reversal potential for IPB toward K+ equilibrium potential. Pentobarbital increased the inward K+ rectifier, IKir, and leak current, Ileak. We determined the susceptibility of IPSCs, evoked by reticular stimulation, to antagonism by bicuculline, picrotoxinin and 2-hydroxysaclofen and identified their receptor subclass components. At EC50 = 53 microM, pentobarbital increased the duration of IPSCs. The prolonged IPSC duration during pentobarbital was attributable to enhanced open probability of GABAA channels, because combined with GABA, pentobarbital application increased mean channel open time without affecting channel conductance. At concentrations up to 100 microM, pentobarbital did not directly activate GABAA receptors. The concentration-response relationships for pentobarbital effects on the intrinsic currents and IPSCs overlapped, implying multiple sites of action and possible redundancy in anesthetic mechanisms. This is the first study to show that an i.v. anesthetic modulates the intrinsic currents, Ih, IKir, and Ileak, as well as IPSC time course in the same neurons. These effects likely underlie inhibition in thalamocortical neurons during pentobarbital anesthesia.

Action Potentials↗